Sabine Strehl Selected Research

Sabine Strehl Research Topics

8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2014
7	Leukemia 01/2022 - 02/2008
5	Neoplasms (Cancer) 01/2022 - 04/2010
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014 - 06/2005
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2010 - 01/2010
2	Pathologic Complete Response 04/2010 - 01/2010
2	Hematologic Neoplasms (Hematological Malignancy) 09/2005 - 06/2005
1	Residual Neoplasm 01/2019
1	B-Cell Leukemia (Leukemia, B Cell) 01/2017
1	Plasmacytoma 04/2014
1	Down Syndrome (Down's Syndrome) 10/2008
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2008
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 05/2006
1	Breast Neoplasms (Breast Cancer) 01/2003

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2005
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2005
5	Transcription Factors (Transcription Factor)IBA 08/2019 - 04/2010
2	Phosphotransferases (Kinase)IBA 01/2022 - 07/2021
2	nuclear pore complex protein 98IBA 09/2005 - 06/2005
2	Nuclear Pore Complex Proteins (Nucleoporins)IBA 09/2005 - 06/2005
1	Interleukin-7 (Interleukin 7)IBA 01/2022
1	GlucocorticoidsIBA 12/2017
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2016
1	SeptinsIBA 05/2010
1	Prednisone (Sone)FDA LinkGeneric 04/2010
1	CytokinesIBA 10/2008
1	Janus Kinase InhibitorsIBA 10/2008
1	AntigensIBA 02/2008
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2006
1	Complementary DNA (cDNA)IBA 01/2003

4	Therapeutics 01/2019 - 01/2010
1	ICE protocol 4 01/2014